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Introduction
 
The integrin family of cell surface glycoproteins plays a
major role in the interaction of cells with the extracellular
matrix (Aplin et al., 1998; Giancotti and Ruoslahti, 1999).
Integrins exist as 
 
a
 
/
 
b
 
 heterodimers and each subunit has a
large extracellular domain, a single helical transmembrane
domain, and, typically, a relatively short cytoplasmic do-
main. At specialized sites of cell–matrix adhesion, termed
focal contacts, integrin cytoplasmic domains articulate, di-
rectly or indirectly, with various proteins, including talin,
 
a
 
-actinin, vinculin, paxillin, tensin, and focal adhesion ki-
nase (FAK),
 
1
 
 that are involved in coupling between inte-
grins and the actin cytokeleton (Burridge and Chrza-
nowska-Wodnicka, 1996). Integrin–cytoskeletal linkages
play a critical role in cell adhesion, determination of cell
shape, and cell motility (Burridge and Chrzanowska-Wod-
nicka, 1996; Miyamoto et al., 1998). Integrins also play an
 
important role in signal transduction processes, either
by directly generating signals or by modulating signals
generated by other receptors (Clark and Brugge, 1995;
Schwartz, 1997; Aplin et al., 1998, 1999a; Giancotti and
Ruoslahti, 1999). Integrin modulation of signaling affects
control of the cell cycle (Assoian, 1997) and regulation of
programmed cell death (Frisch and Ruoslahti, 1997).
The cytoplasmic domains of integrins play a key role in
their function. Thus, the 
 
b
 
 chain cytoplasmic tail has been
implicated in the recruitment of integrins to focal contacts
(Reszka et al., 1992), activation of FAK (Akiyama et al.,
1994), and determining the affinity of integrins for their
ligands (Wang et al., 1997). Similarly, the 
 
a
 
 subunit cyto-
plasmic tail has been implicated in regulation of integrin
affinity (O’Toole et al., 1994) and control of cell motility
(Chan et al., 1992; Bauer et al., 1993).
Integrins can interact with a variety of partner proteins,
including various membrane receptors that bind to the
extracellular and transmembrane domains of integrins
(Hemler, 1998; Porter and Hogg, 1998), as well as intracel-
lular proteins that associate with integrin cytoplasmic tails
(Aplin et al., 1998). Yeast two-hybrid techniques have
been used to identify several proteins that interact with in-
tegrin 
 
b
 
 subunit cytoplasmic domains and that have inter-
esting and important biological functions (Kolanus et al.,
1996; Biffo et al., 1997; Chang et al., 1997; Kashiwagi et al.,
1997; Delcommenne et al., 1998; Li et al., 1999; Zhang and
Hemler, 1999). Fewer proteins have been reported to in-
teract with 
 
a
 
 chain cytoplasmic domains. Thus, calreticulin
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Abstract. 
 
Integrins have been implicated in key cellu-
lar functions, including cytoskeletal organization, motil-
ity, growth, survival, and control of gene expression.
The plethora of integrin 
 
a
 
 and 
 
b
 
 subunits suggests that
individual integrins have unique biological roles, im-
 
plying speciﬁc molecular connections between inte-
grins and intracellular signaling or regulatory pathways.
Here, we have used a yeast two-hybrid screen to iden-
tify a novel protein, termed Nischarin, that binds pref-
erentially to the cytoplasmic domain of the integrin 
 
a
 
5
subunit, inhibits cell motility, and alters actin ﬁlament
organization. Nischarin is primarily a cytosolic protein,
but clearly associates with 
 
a
 
5
 
b
 
1, as demonstrated by
coimmunoprecipitation. Overexpression of Nischarin
markedly reduces 
 
a
 
5
 
b
 
1-dependent cell migration in
several cell types. Rat embryo ﬁbroblasts transfected
with Nischarin constructs have “basket-like” networks
of peripheral actin ﬁlaments, rather than typical stress
ﬁbers. These observations suggest that Nischarin might
affect signaling to the cytoskeleton regulated by Rho-
family GTPases. In support of this, Nischarin expres-
sion reverses the effect of Rac on lamellipodia forma-
tion and selectively inhibits Rac-mediated activation of
the c-fos promoter. Thus, Nischarin may play a negative
role in cell migration by antagonizing the actions of Rac
on cytoskeletal organization and cell movement.
Key words: integrin • Rac • cell migration • cytoskel-
eton • two hybrid 
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has been reported to bind the conserved GFFKR motif
found in all 
 
a
 
 chains and to modulate integrin affinity
(Coppolino et al., 1997), whereas calcein integrin binding
protein (CIB) is a calcium-binding protein that associates
specifically with the cytoplasmic domain of 
 
a
 
IIb, possibly
playing a role in activation of the 
 
a
 
IIb
 
b
 
3 integrin (Naik et
al., 1997).
The 
 
a
 
5
 
b
 
1 integrin, a receptor for fibronectin, seems to
play a special role in regulating growth and survival in
some cell types. Thus, high expression of 
 
a
 
5
 
b
 
1 has been
linked with reductions in tumor cell growth rates both in
vitro and in vivo (Giancotti and Ruoslahti, 1990; Schreiner
et al., 1991; Varner et al., 1995). Surprisingly, 
 
a
 
5
 
b
 
1 also
plays a unique role in protecting cells against apoptosis
triggered by mitogen deprivation (Zhang et al., 1995;
O’Brien et al., 1996; Lee and Juliano, 2000). In addition,
 
a
 
5
 
b
 
1 has been reported to regulate muscle cell growth and
differentiation (Sastry et al., 1999). These data suggest that
certain effects of 
 
a
 
5
 
b
 
1 on growth or apoptosis may be 
 
a
 
5
specific, and thus, there may be intracellular proteins that
selectively interact with the 
 
a
 
5 cytoplasmic tail to mediate
these events. Accordingly, we have made use of the yeast
two-hybrid system to identify proteins that bind to the 
 
a
 
5
cytoplasmic domain. We have identified a novel protein
that associates with the cytoplasmic tail of the 
 
a
 
5 subunit,
and, to a minor degree, with cytoplasmic domains of other
 
a
 
 subunits, and that strongly affects cell migration and in-
fluences cytoskeletal organization. We named this novel
protein Nischarin, which is derived from a term in classic
Sanskrit that connotes slowness of motion. This designa-
tion is based on the finding, shown below, that overexpres-
sion of Nischarin dramatically impairs cell migration.
 
Materials and Methods
 
Yeast Two-Hybrid Screening
 
Here, L40 (Mata his3
 
D
 
200 trp1-901, 112 ade2 LYS2::(lexAop)
 
4
 
-HIS3
URA3(lexAop)8-LacZ Gal4) and AMR70 (Mata his3 lys2 trp1 leu2
URA3::(lexAop)
 
8
 
-LacZ Gal4) yeast strains were used (gifts from Dr. Stan
Hollenberg, Vollum Institute, Oregon Health Sciences University, Port-
land, OR). Yeast two-hybrid screening was conducted as previously de-
scribed (Vojtek et al., 1993). The pBTM 
 
a
 
5 plasmid, which has the 
 
a
 
5 cy-
toplasmic domain fused to the LexA DNA-binding domain and with a
tryptophan marker, was transformed into yeast strain L40 and selected for
tryptophan prototrophy. Plasmids (pVp16) containing mouse embryonic
cDNA libraries of 9.5 and 10.5 d fused to the VP16-transactivating domain
and a leucine marker were transformed into the L40 strain containing the
bait plasmid and screened for leucine, tryptophan, and histidine prototro-
phy. A total of 1.7 
 
3
 
 10
 
7
 
 transformants were screened for positives. The li-
braries and vectors were gifts from Dr. Stan Hollenberg. Histidine-posi-
tive colonies were further tested for LacZ activation. Dual positives were
further confirmed for specificity of the interaction using various baits and
included integrin 
 
b
 
1, 
 
a
 
2, and 
 
a
 
v cytoplasmic domains, as well as lamin, an
irrelevant protein in this context. Specificity of the interaction was con-
firmed by mating experiments. The pBTM bait plasmids were “cured”
from dual-positive clones by growth in nonselective medium. The pres-
ence of the library plasmids with inserts in the “cured” clones was con-
firmed by PCR using vector-specific primers. AMR 70 strain cells were
transformed separately with pBTM 
 
a
 
5, pBTM 
 
b
 
1, pBTM 
 
a
 
v, pBTM 
 
a
 
2,
pBTM lamin, or pBTM vector alone. These transformed cells were mated
with the “cured” L40 cells that contained positive pVP16 library plasmids.
 
Cloning of Full-Length Nischarin
 
To clone full-length Nischarin, we screened a mouse brain library in the
lambda Zap II vector (Stratagene). Using a colony hybridization tech-
nique, 
 
z
 
30,000 plaques were screened with a 
 
32
 
P-labeled PCR product
consisting of 0.45 kb of the integrin-binding region of Nischarin. From this
screen, one strong positive plaque was identified and confirmed in two
further rounds of screening. Sequence analysis of this clone (A3.1) indi-
cated that the sequence was incomplete at the 3
 
9
 
 end. Using a different
PCR probe, the lambda Zap library was screened again to obtain the re-
mainder of the Nischarin cDNA. This screen gave several positives, and
the longest clone (clone 14.2) was picked. Clones A3.1 and 14.2 provided
the complete open reading frame (ORF) of Nischarin.
 
DNA Constructions and Transfection
 
The construction of two-hybrid bait plasmids, GST chimeras, and partial-
and full-length myc-tagged Nischarin mammalian expression constructs
followed standard recombinant DNA procedures. Clones A3.1 and 14.2,
mentioned above, were used to make full-length expression constructs.
Full details are available upon request. A chimera comprised of full-
length Nischarin and GFP was prepared by an inframe insertion of the
coding region of Nischarin into the pE-GFP-N1 vector (CLONTECH
Laboratories, Inc.). Expression plasmids for CD4, human 
 
a
 
2, and 
 
a
 
v inte-
grin subunits were obtained from Drs. R. Nicholas (University of North
Carolina-Chapel Hill, Chapel Hill, NC), L. Parise (University of North
Carolina-Chapel Hill), and David Cheresh (The Scripps Research Insti-
tute, La Jolla, CA), respectively. Transfection of mammalian cell lines
was usually done with Lipofectamine (GIBCO BRL) or Superfect
(QIAGEN), according to the manufacturer’s specifications.
 
Northern Blot Analyses
 
A mouse multiple tissue Northern blot (CLONTECH Laboratories, Inc.)
was probed with a 0.45-kb fragment of the 
 
a
 
5 integrin–binding region of
Nischarin (probe 1) (nucleotides 1,305–1,743), with fragments from the far
5
 
9
 
 end (probe 2) (nucleotides 
 
2
 
334–
 
1
 
56], or the 3
 
9
 
 end (probe 3)(nucle-
otides 2,936–3,748). RNA was isolated from various cell lines, run on aga-
rose-formaldehyde gels, and hybridized with probes 1–3, using previously
described techniques (Alahari et al., 1996).
 
Antibodies
 
The predicted ORF of Nischarin was used to design two peptides repre-
sented at the far COOH terminus of the protein. The peptides (EAL-
CGRELPVELTGA-C and LDDGRRVRDLDRVL-C) were obtained
from the University of North Carolina-Protein Core Laboratory. Both
peptides were conjugated to keyhole limpet hemocyanin (Pierce Chemical
Co.) and sent to Aves Laboratories for production of chicken pAbs. Anti-
 
a
 
5 cytoplasmic domain pAb was a gift from Richard Hynes (Massachu-
setts Institute of Technology, Cambridge, MA). Anti-myc mAbs and
pAbs were purchased from Babco. pAbs to 
 
a
 
v cytoplasmic domain were
provided by Guido Tarone (University of Torino, Torino, Italy). Rat anti–
mouse 
 
a
 
5 mAb, and control rat IgG were purchased from PharMingen
and Sigma-Aldrich, respectively. mAbs to vinculin and phosphotyrosine
were purchased from Sigma-Aldrich and Upstate Biotechnology. Fluores-
cent phalloidin was bought from Sigma-Aldrich. A partially purified prep-
aration of the human 
 
a
 
5
 
b
 
1 integrin (Chemicon) was sometimes used as a
control.
 
Binding To GST Fusion Proteins
 
GST–Nischarin fusion proteins expressed from pGEX vectors (Amer-
sham Pharmacia Biotech) were prepared in a standard manner and bound
to glutathione-Sepharose 4B beads for “pull down” experiments. CHO
cells (clone B2
 
a
 
27), which overexpress the human 
 
a
 
5 integrin subunit,
were used as the source of integrins (Bauer et al., 1993). 
 
a
 
5-deficient cells
(CHO B2) were used as controls. CHO cells were lysed in a buffer con-
taining nonionic detergent and protease inhibitors. The CHO lysate was
added to the GST protein–containing beads, incubated for 1 h at 4
 
8
 
C, and
washed four times with buffer. Bound CHO proteins were eluted by boil-
ing in 2
 
3
 
 SDS sample buffer and analyzed by Western blotting using anti-
 
a
 
5 cytoplasmic domain antibody.
 
Coimmunoprecipitation Experiments
 
CHO B2
 
a
 
27 and B2 cells were transiently transfected with myc vector,
myc-Nischarin (434–581), or myc-Raf. After 48 h of transfection, cells
were lysed in a 0.5% Triton X-100 buffer. These lysates were immunopre-
cipitated with anti-myc antibody, resolved by 7% SDS-PAGE, electro-
phoretically transferred to nylon membranes, and Western blotted with
anti-
 
a
 
5 cytoplasmic domain antibody. In further studies with full-length
Nischarin, cells were lysed in a buffer containing 0.1% Triton X-100
(Borowsky and Hynes, 1998). In one set of experiments, lysates of Cos7
cells cotransfected with myc-Nischarin and 
 
a
 
5, 
 
a
 
v, or CD4, were immuno- 
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precipitated with anti-myc and blotted with anti-
 
a
 
5 extracellular domain
antibody (Transduction Laboratories), anti-
 
a
 
v, or anti-CD4 antibodies
(Santa Cruz Biotechnology, Inc.). For mouse NB41A3 cells, endogenous
 
a
 
5 was immunoprecipitated with rat anti-
 
a
 
5 mAb and the immunoprecip-
itate was blotted for endogenous Nischarin using the chicken anti-Nis-
charin pAb described above.
 
Cell Migration Experiments
 
Wound-type cell migration experiments were performed as described pre-
viously (Bauer et al., 1992, 1993), with minor modifications. In brief, 3T3
cells were cotransfected with 1 
 
m
 
g of 
 
b
 
-galactosidase plasmid and various
amounts of full-length myc-Nischarin construct and plated on gridded tis-
sue culture dishes. After 48 h, the cell layer was scraped along the center
of the dish with a sterile razor blade. After overnight incubation at 37
 
8
 
C in
serum-containing medium, cells migrating into the scraped area were de-
tected by staining for 
 
b
 
-galactosidase. The percent of transfected cells that
migrated across the line and into the denuded area was calculated by
counting blue cells in several gridded fields from the unscraped area and
in several fields from the scraped area. At least 50 migrant cells were
counted for each condition. The ratio of migrant transfected cells to total
transfected cells 
 
3
 
100 was taken as the percent migration.
Cell migration studies using Nischarin-transfected or control-trans-
fected 3T3 cells or CHO cells were also performed using a transwell assay,
according to a previously described procedure (Keely et al., 1997). The
transfected cells were marked by use of a GFP expression plasmid. Fi-
bronectin or other matrix proteins were coated on the underside of the
transwell, the cells were plated on the upper surface, and the percent of
Nischarin or control transfectants migrating across the 8-
 
m
 
m pore size
membrane was determined by visual inspection in a fluorescence micro-
scope after overnight incubation in BSA-containing medium. Transwell
experiments were performed with wild-type 3T3 cells, 3T3 sublines over-
expressing human 
 
a
 
5 or 
 
a
 
2 subunits (Aplin et al., 1999b), and CHO B2
cells lacking 
 
a
 
5, as well as CHO B2a27, its 
 
a
 
5 transfectant (Bauer et al.,
1993).
 
Subcellular Fractionation
 
Cos7 cells transfected with myc-Nischarin and untransfected Neuro 2A
cells were subjected to subcellular fractionation, as described previously
(Gu and Majerus, 1996), with minor modifications. Cell lysates were cen-
trifuged briefly at 1,500 rpm to remove nuclei and intact cells. The super-
natant was further spun at 100,000 
 
g
 
 for 30 min at 4
 
8
 
C; this supernatant
was considered to be the cytosolic fraction. The pellet was solubilized in a
1% Triton X-100–containing solution and centrifuged at 100,000 
 
g
 
 for 30
min; this supernatant was considered to be the membrane fraction. Mem-
brane and cytosolic fractions were resolved by 8% SDS-PAGE, electro-
phoretically transferred onto a nylon membrane, and blotted with anti-
Nischarin antibodies, as described above.
 
Fluorescence Microscopy
 
Immunofluorescence studies with antibodies to integrins or focal contact
proteins were conducted according to procedures described previously
(Burridge et al., 1992). Rat embryonic fibroblasts (REFs) were cotrans-
fected with 1 
 
m
 
g of GFP plasmid and 2 
 
m
 
g of myc-Nischarin plasmid, or 1
 
m
 
g of GFP alone, per well on six-well plates. After 48 h, cells were
trypsinized and plated onto fibronectin-coated cover slips for 3 h in se-
rum-containing medium. The cells were washed three times with cold
PBS, fixed for 10 min in 0.37% formaldehyde, and permeabilized in
1%Triton X-100 for 5 min. Then, cells were washed several times and
blocked in 2% BSA for 1 h at room temperature. Primary antibody incu-
bation was done in a moist chamber overnight in a cold room. Anti-tubu-
lin, anti-PY, anti-vinculin, and anti-vimentin antibodies were used at a di-
lution of 1:100. After rinsing in PBS, coverslips were incubated with an
appropriate TRITC-conjugated secondary antibody for 1 h at room tem-
perature. For actin staining, cover slips were incubated with TRITC-phal-
loidin (1:1,000) for 15 min.
In some cases, the subcellular distribution of Nischarin was evaluated
using the full-length Nischarin–GFP chimera described above. This was
transfected into 3T3 cells at a level of 2 
 
m
 
g per well (it should be noted
that levels of expression of Nischarin–GFP chimeric protein were substan-
tially lower than expression of myc-Nischarin protein when equivalent
amounts of plasmid were transfected). After 48 h of transfection, cells
were plated onto fibronectin coverslips, as described above, and incubated
with antibodies to vinculin or integrins, and then with TRITC-conjugated
secondary antibody, or with TRITC-phalloidin to visualize actin. In all
cases, coverslips were observed on a ZEISS Axioscop fluorescence micro-
 
scope using a 40
 
3
 
 oil immersion objective. Images were recorded using a
CCD camera and a computer with Metamorph image analysis software.
 
Rho GTPase Experiments
 
For studies on Rho-mediated signaling, NIH 3T3 cells were cotransfected
with 1 
 
m
 
g of luciferase reporter under the control of the c-fos promoter
(c-fos–Luc) (Hill et al., 1995), 3 
 
m
 
g of pAX142 vector, pAX142 Rac Q61L
(Whitehead et al., 1988), or an activated MEK construct (pFC-MEK1;
Stratagene) and various amounts of pcDNA myc-Nischarin or pcDNA
vector, using Superfect. The pAX142 vectors were provided by Drs. I.
Whitehead and C. Der (University of North Carolina-Chapel Hill). After
4 h of transfection, cells were washed with PBS, maintained in 0.5% serum
for 24 h, and lysed in luciferase buffer, as described above. Additional ex-
periments were done with commercial luciferase reporter systems (Strat-
agene) using either Rac-driven c-Jun transcriptional activation or protein
kinase A–driven activation of the cyclic AMP–response element (CRE)-
response element. In all transfections, DNA quantities were normalized
with the pcDNA vector. Luciferase activity was measured by normalizing
for total protein content or by coexpression of 
 
Renilla
 
 luciferase.
To study the effect of Rho-family GTPase on the cytoskeleton, 3T3
cells were transfected with a plasmid expressing an activated (Q61L) form
of Rac and with a Nischarin plasmid or with a vector control. A small
amount of a GFP-expressing plasmid was used to mark the transfectants.
After 48 h, the actin filaments were stained with TRITC-phalloidin and
the cells were observed by fluorescence microscopy, as described above.
 
Results
 
Detection of a Novel 
 
a
 
5-interacting Protein
 
We used a yeast two-hybrid screen to identify proteins
that interact with the 
 
a
 
5 cytoplasmic domain. A protein
composed of the complete cytoplasmic tail of 
 
a
 
5 fused
with the DNA-binding domain of Lex A was expressed
from the yeast plasmid pBTM
 
a
 
5. We searched mouse
embryonic libraries for proteins that interact with the
 
a
 
5 cytoplasmic tail. Protein domains from the libraries
were fused to the VP16-transactivating domain and ex-
pressed from the yeast plasmid pVP16. Cotransformants
of pBTM
 
a
 
5 and pVP16 in the yeast L40 were screened for
conversion to histidine prototrophy. Out of 1.7 
 
3
 
 10
 
7
 
transformants screened, 120 colonies were positive for his-
tidine; of those, 45 were also positive for LacZ activation.
To determine specificity, several other “baits” were tested
for interaction with the 
 
a
 
5-binding library protein(s). In
particular, we tested for interactions with the cytoplasmic
domains of the 
 
a
 
2, 
 
a
 
v, or 
 
b
 
1 integrin subunits, or with the
irrelevant protein lamin. As seen in Fig. 1 and Table I, the
 
a
 
5 bait strongly interacted with the library protein and ac-
tivated expression of the histidine and LacZ markers. The
Table I. Summary of Yeast Two-Hybrid Interactions
Nischarin
Baits
Histidine
prototrophy
b-gal
positivity
a5 tail 1111 1111
a2 tail 12 2
av tail 12 2
b1 tail 22 22
Lamin 22 22
Vector 22 22
The AMR 70 yeast strain, which is suitable for mating with the L40 strain, was
transformed with pBTM a5, pBTM a2, pBTM av, pBTM lamin, or pBTM vector
alone. These cells were mated with L40 cells that contained Nischarin-positive pVP16
library plasmids to yield diploids. Positive interactions were detected by b-galactosidase
assay and histidine prototrophy, whereas growth of only diploid cells was assured by
use of selective media.The Journal of Cell Biology, Volume 151, 2000 1144
av and a2 baits only weakly activated the histidine re-
porter, and were unable to activate LacZ. These data sug-
gest that the a5-positive library protein may interact
weakly with several integrin a subunits, but binds strongly
to the a5 subunit.
Restriction enzyme analysis and DNA sequencing re-
vealed that the insert in all positives tested was comprised
of the identical 450 nucleotide sequence. This sequence
comprises an ORF, but no start or stop codons. To find the
full-length sequence of this cDNA, we screened a mouse
brain library in the lambda zap II vector. We identified two
overlapping cDNA fragments; and sequence analysis of
these fragments revealed the complete ORF for this gene.
This consists of 4,062 nucleotides and codes for a novel
protein of 1,354 amino acids, with a predicted molecular
weight of 148,053. As mentioned above, we have termed
this protein Nischarin, a name which describes its effects
on cell migration. The predicted amino acid sequence of
Nischarin is shown in Fig. 2. The validity of this ORF as a
protein-coding region is suggested by the presence of a
well conserved Kozak sequence immediately 59 of the
ATG, the presence of a poly A tail in the 39 untranslated
region, the fact that the observed message size (5.5 kb, see
below) is consistent with the cDNA size, and the fact that
several mouse expressed sequence tags, which have the
correct reading frame, overlap our predicted ORF region.
Homologies with Other Proteins
BLAST analysis indicates that Nischarin lacks significant
homology with any known protein with a well-described
function. A close human homologue of Nischarin pro-
tein has been reported in Genbank (sequence data avail-
able from GenBank/EMBL/DDBJ under accession no.
AF082516). It has been suggested, based on limited evi-
dence (Ivanov et al., 1998), that this protein is a neurore-
ceptor for imidazoline compounds. The human protein is
very similar to Nischarin. Thus, there is 82% identity in a
792 NH2-terminal region that includes the 150 residue in-
tegrin-binding region originally identified by two-hybrid
screening. There is also 84% identity in a 400 residue
COOH-terminal region. However, there is less homology
in the central proline-rich region (see below). The NH2-
terminal region of Nischarin also displays a strong homol-
ogy to a Caenorhabditis elegans protein (sequence data
available from GenBank/EMBL/DDBJ under accession
no. Z69383) of unknown function that resembles the regu-
latory subunits of protein phosphatases. In addition, there
are two Drosophila homologues of the NH2-terminal re-
gion (AE003611 and AE003811). When BLAST searching
is performed with the filter for low complexity regions in-
activated, the central region of Nischarin, which has multi-
ple repeats of proline, alanine, and glutamic acid residues,
is found to resemble regions seen in neurofilament pro-
teins (e.g., accession no. Z31012) and dermal proteins (ac-
cession nos. P17437 and X51394). Despite the existence of
Figure 1. Two-hybrid analysis for specificity of Nischarin interac-
tions. (A) Activation of His3 by a subunits. A yeast strain that con-
tains the a5-reactive (Nischarin) fragment isolated from the yeast
library screen was transformed with a5, av, a2, and b1 cytoplasmic
tails and lamin and screened for histidine transactivation. The left
side confirms the presence of the bait and library plasmids by
growth on tryptophan- and leucine-deficient plates (2TL). The
transformants were tested for their ability to grow on histidine-
deficient plates containing 0.5 mM 39-amino-1,2,4,-triazole. The
b1-transformed cells have growth similar to lamin-transformed
or -untransformed yeast cells and are considered to be at back-
ground levels. (B) Activation of the lacZ reporter gene. This dip-
loid interaction analysis was performed as described in Materials
and Methods. The left two panels show growth of the diploids on
selective media that excludes growth of haploid cells. The right two
panels show X-gal staining of these diploids and illustrates that use
of an integrin a5 subunit cytoplasmic domain bait plasmid activates
b-galactosidase, whereas use of a b1 subunit bait plasmid does not.
Results using several bait plasmids are summarized in Table I.
Figure 2. The primary sequence of Nischarin (sequence data avail-
able from GenBank/EMBL/DDBJ under accession no. AF315344).
The amino acid sequence of the Nischarin ORF is shown. Notable
features include (a) the proline-rich region (795–955), (b) the cyto-
chrome motif (558–567), and (c) two leucine-zipper motifs (449–470)
and (1211–1232). The integrin-binding region identified in the origi-
nal two-hybrid screen (434–581) is in bold. Potential SH3 domain–
binding sites are indicated by dotted underlining. The COOH-termi-
nal peptides used for chicken antibody production are underlined.Alahari et al. Novel Integrin-binding Protein Inhibits Cell Migration 1145
a highly proline-rich region, no consensus-binding sites for
SH3 domains (Sparks et al., 1996) were identified in this
region (however, see below). The integrin-binding region
of Nischarin identified in the two-hybrid screen does not
have any close homologues other than in its human direct
counterpart. We have used several software programs to
look for specific functional motifs that might be present in
Nischarin. Aside from the few exceptions noted below, we
were unable to find well-known protein functional motifs
in Nischarin. There is a cytochrome p450 motif (FHADL-
RSCFA) 558–567 that may be indicative of an enzymatic
function; there are two leucine zipper repeats 449–470
and 1,211–1,232 (LGADEDFLLEHIRILKVLWCFL and
LGRGRGPLRPKTLLLTSAEIFL) that may be predic-
tive of protein–protein interaction sites. There are also po-
tential SH3 domain–binding motifs, two in the NH2-termi-
nal region and two in the COOH-terminal region. Thus,
the primary sequence of Nischarin offers few clues to the
biological function of this protein.
Nischarin Binds Integrin a5 Subunit In Vitro
and In Vivo
To confirm that the interaction between the a5 cytoplas-
mic tail and Nischarin detected by two-hybrid analysis also
occurs in vitro, two GST–Nischarin constructs were made,
GST–Nisch (435–582) and GST–Nisch (33–588). GST–
Nisch (435–582) corresponds to the integrin-binding re-
gion of Nischarin identified in the two-hybrid system,
whereas the second construct contains additional NH2-ter-
minal residues. The Nischarin–GST fusion proteins were
immobilized on a glutathione-agarose matrix and incu-
bated with purified a5b1 protein, with a cell lysate of
CHO B2a27 (human a5–transfected cells) or CHO B2
(a5-deficient cells). The proteins retained on the glu-
tathione matrix were analyzed by SDS-PAGE and immu-
noblotting for a5. Consistent with the yeast data, the
GST–Nischarin fusion proteins, but not GST alone, were
able to interact with purified a5b1 or with a5b1 from a cell
lysate (Fig. 3 A). These data indicate Nischarin binds the
a5 integrin subunit in vitro.
Several types of coimmunoprecipitation experiments
were performed to confirm that Nischarin interacts selec-
tively with the a5 integrin subunit in mammalian cells. First,
CHO B2a27 cells were transiently transfected with a con-
struct expressing a truncated myc epitope–tagged segment
of Nischarin (435–582), with myc-tagged Raf, or with myc
vector alone. Cells were lysed in a buffer containing non-
ionic detergent, immunoprecipitated with anti-myc anti-
body, and blotted with anti-a5 or anti-myc antibodies.
Western blotting with anti-a5 antibody indicated that a5
coimmunoprecipitated with anti-myc antibody only in cells
transfected with myc-Nischarin (435–582), but not in cells
transfected with myc-Raf or myc vector alone (Fig. 3 B).
Expression of similar amounts of myc-Nischarin and myc-
Raf was confirmed by Western blotting (data not shown).
In experiments with CHO B2 cells, which lack a5, Nischarin
did not coimmunoprecipitate a band in the a5 region. This
indicates that myc-tagged Nischarin (435–582), but not an
irrelevant myc-tagged protein, can bind a5b1 integrin.
Further coimmunoprecipitation experiments were done
using full-length Nischarin. To show that Nischarin inter-
acts preferentially with a5 integrins and not with other
transmembrane proteins, coimmunoprecipitations were
done with CD4, another protein having a single transmem-
brane domain. Cos 7 cells were transiently cotransfected
Figure 3. Specific binding of Nischarin to a5b1 in
vitro and in vivo. (A) GST pull-down experiments
were performed as described in Materials and
Methods. Cell lysates using a nonionic detergent
were obtained from a5 positive–CHO B2a27 cells.
Alternatively, a partially purified a5b1 was used.
The GST proteins used were GST–Nisch (435–
582), GST–Nisch (33–588), and unmodified GST;
these were bound to glutathione-Sepharose beads.
The lysate material retained on the GST beads was
resolved by SDS-PAGE and Western blotted with
an anti-a5 antibody. The a5 band is marked with
an arrowhead. Lane 1, purified a5b1; lanes 2–4,
pull-downs of partially purified a5b1 by GST,
GST–Nisch(435–582), GST–Nisch(33–588); lane 5,
lysate from CHO B2a27 cells; lanes 6–8, pull-
downs of B2a27 lysate by GST, GST–Nisch(435–
582), GST–Nisch(33–588). (B) a5 positive–CHO
B2a27 cells and a5 negative–CHO B2 cells were
transiently transfected with plasmids expressing myc-Nisch (435–582), myc-Raf, or with empty vector. Transfected cell lysates were immuno-
precipitated with anti-myc antibody, followed by Western blotting with an anti-a5 antibody. The a5 band is marked with an arrowhead. Lane
1, lysate from CHO B2 cells; lane 2, lysate from CHO B2a27 cells; lanes 3–5, anti-myc immunoprecipitates from CHO B2 cells; lanes 6–8 anti-
myc immunoprecipitates from CHO B2a27 cells. (C) Cos 7 cells were transiently cotransfected with full-length myc-Nischarin and a5 plasmid
or myc-Nischarin and CD4 plasmid. The lysates were immunoprecipitated with anti-myc antibody and blotted with anti-a5 antibody (Trans-
duction labs) or anti-CD4 antibody (Santa Cruz Biotechnology, Inc.). The first three lanes represent lysates from a5 and myc-Nischarin–trans-
fected cells in three different experiments and the next three lanes represent their respective myc immunoprecipitates. On the right
side, CD4- and myc-Nischarin–transfected cell lysate and its myc immunoprecipitate are shown. The bottom row indicates the expression of
myc-Nischarin in all conditions. (D) Cos 7 cells were transiently cotransfected with myc-Nischarin and a5 or av plasmids. Myc immunopre-
cipitates and lysates were Western blotted with a5 or av antibodies. In each western blot, the first lane is lysate and the second lane is its myc-
immunoprecipitate, both blotted with anti-integrin subunit antibodies. In panel (E) lysates of mouse NB41A3 cells were exposed either to rat
anti–mouse a5 monoclonal IgG or an equivalent amount of native rat IgG; the lysates were then precipitated using protein G agarose beads.
The immunoprecipitates were then Western blotted with either chicken anti-Nischarin antibody (top) or anti-a5 antibody (bottom).The Journal of Cell Biology, Volume 151, 2000 1146
with myc-Nischarin and pcDNA-a5 or myc-Nischarin and
pcDNA-CD4. These cells were lysed and myc immunopre-
cipitates were processed for blotting with anti-a5 or anti-
CD4 antibodies. As shown in Fig. 3 C, myc-Nischarin spe-
cifically immunoprecipitated a5, but not CD4.
To further examine the alpha subunit selectivity of Nis-
charin, Cos 7 cells were cotransfected with myc-Nischarin
and plasmids expressing the human a5 or av subunits.
These cells were lysed and myc immunoprecipitates were
processed for blotting with anti-a5 or anti-av antibodies.
As seen in Fig. 3 D, Nischarin coimmunoprecipitated sub-
stantial amounts of a5, but barely detectable av subunits.
Thus, the strong preference of Nischarin for the a5 sub-
unit, which was detected in the two-hybrid analysis, seems
to be borne out in the cellular setting.
Coimmunoprecipitation experiments were also done
for endogenous Nischarin and endogenous a5 subunit.
NB41A3 cells, a mouse neuronal-derived line, were lysed
and immunoprecipitates formed using rat anti–mouse a5
mAb, or rat IgG as a control. The immunoprecipitates
were Western blotted using chicken anti-Nischarin pAb.
As seen in Fig. 3 E, a band for Nischarin was detected in
the a5 immunoprecipitate, but not in the control. It was
not possible to examine other integrin a–subunit imuno-
precipitates, since only low levels of expression were
found in NB41A3 cells for other integrins for which anti–
mouse mAb are available.
The experiments shown in Fig. 3 A–E indicate: (a) full-
length Nischarin or truncated Nischarin (435–582) can
bind to the a5 integrin subunit, (b) other proteins (e.g.,
myc-Raf) do not bind a5 under the conditions used for im-
munoprecipitation, and (c) full-length Nischarin does not
bind to coexpressed irrelevant proteins. Furthermore, Nis-
charin seems to prefer the a5 subunit compared with other
tested a subunits. These findings demonstrate a selective
interaction between Nischarin and the a5 integrin subunit
in mammalian cells. This interaction is able to occur under
physiological conditions, as indicated by the coimmuno-
precipitation of endogenous a5 and Nischarin.
Tissue Distribution of Nischarin
To determine the tissue distribution of Nischarin mRNA,
a mouse multiple tissue Northern blot was hybridized with
a PCR probe from the Nischarin integrin-binding region.
A single mRNA of z5.5 kb was detected. In further analy-
sis (not shown), three probes from different regions of the
cDNA (extreme 59 end, integrin-binding region, and ex-
treme 39 end of the ORF) were used; all three probes de-
tected the same message. Nischarin mRNA expression
was highest in brain and kidney, expression levels were
lower in heart, liver, lung, and skeletal muscle, whereas no
expression was seen in spleen and testis (Fig. 4 A). To ad-
dress the expression of Nischarin in various cell types, we
performed Northern blot analysis on several cell lines. Nis-
charin message was present in various rodent epithelial, fi-
broblast, and neuronal cell lines, though higher levels
tended to be present in neuronal cells (Fig. 4 B and data
not shown). Analysis of a mouse embryo RNA blot indi-
cated the presence of Nischarin message as early as 7 d of
development (Fig. 4 C).
Expression of Nischarin in Cells and Its 
Subcellular Localization
The expression of transfected myc-tagged full-length Nis-
charin and expression of endogenous Nischarin were eval-
uated by Western blotting of cell lysates with anti-myc
antibodies, as well as chicken pAbs directed against
polypeptides from the COOH-terminal region of the pre-
dicted Nischarin ORF. In Cos7 cells transfected with myc-
tagged full-length Nischarin, both antibodies recognized
the same band of z190 kD (Fig. 5, A and B); this is some-
what larger than the predicted molecular weight of ex-
pressed Nischarin, but the reason for this is unclear. The
expression of endogenous Nischarin was evaluated in de-
tergent lysates of several cell lines by Western blotting
with chicken anti-Nischarin antibodies (Fig. 5 A). In rat in-
testinal epithelial (RIE) cells (Oldham et al., 1996), a pro-
Figure 4. Northern blot analysis of Nischarin message. (A) A
commercial multiple tissue membrane was hybridized with a
0.45-kb Nischarin probe, stripped, and rehybridized with an actin
probe. The position of the 5.5-kb Nischarin message corresponds
to the major band. (B) The same procedure was applied to RNA
extracted from several cell lines. (C) A commercial membrane
containing mouse RNA from several developmental stages was
analyzed by the same procedure.
Figure 5. Expression of Nis-
charin in cell lines. Various
rodent cell lines, as well as
Cos7 cells transfected with
full-length myc-tagged Nis-
charin, were lysed in a non-
ionic detergent–containing
buffer and the lysates were
resolved by SDS-PAGE. The
samples were Western blot-
ted using either anti-myc an-
tibody or a chicken antibody
to a peptide sequence from
the COOH-terminal region
of Nischarin. (A) A compari-
son of the expression of Nis-
charin in several rodent cell
lines and in transfected Cos
cells, using the chicken anti-Nischarin antibody (the Nischarin
bands are marked with arrowheads). (B) The lysates are the
same as in A, except the membrane was blotted with anti-myc an-
tibody, demonstrating that the anti-myc and anti-Nischarin anti-
bodies react with the same protein in transfected Cos cells. (C)
The peptide used for immunization can block the binding of
chicken anti-Nischarin antibody both to endogenous Nischarin in
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tein band of z190 kD was detected; this band comigrated
with the immunoreactive band in Nischarin-transfected
Cos7 cells. In NIH 3T3 cells, the chicken anti-Nischarin
antibody detected a very weak band of 190 kD (data not
shown). In several mouse neuronal cell lines (NIE 119,
NB41A3, BC(3)H1, and Neuro 2A), an immunoreactive
band of somewhat higher apparent molecular weight was
detected (Fig. 5 A, and data not shown). The immunoreac-
tivities of the bands detected in Nischarin-transfected
Cos7 cells, or in nontransfected RIE cells, were competed
out upon addition of the Nischarin COOH-region peptide
used for chicken immunization (Fig. 5 C). Thus, the bands
detected by the chicken antibody in the various rodent cell
lines or in the transfected Cos7 cells are very likely to rep-
resent Nischarin. The detection of immunoreactive bands
of differing apparent molecular weights in the various cell
types examined suggests differences in splicing or post-
translational modifications. The fact that only a single
Nischarin message is seen by Northern analysis seems
to militate against the possibility of splicing differences.
However, alternate splicing of a short region of the
mRNA might not be readily detected. The data of Fig. 5,
A–C, indicate that Nischarin is widely expressed in various
rodent cell lines, with higher levels found in cells of neu-
ronal origin.
Both biochemical and fluorescence microscopy tech-
niques were used to evaluate the subcellular localization
of Nischarin. Overall distribution of Nischarin was assayed
Figure 6. Subcellular localization of Nischarin. (A) Biochemical fractionation data is shown. Unmodified Neuro2A cells and Cos7 cells
transfected with myc-tagged full-length Nischarin were used. Cell homogenates were separated into a 100,000 g cytosolic fraction and a
membrane fraction. Each fraction was resolved by SDS-PAGE and then Western blotted with an anti-myc antibody, or chicken anti-Nis-
charin antibody. On the left side (anti-Nischarin Western blot), lanes represent the membrane fractions from Nischarin-transfected Cos7
cells, untransfected Neuro 2A cells, and untransfected Cos 7 cells. On the right side, lanes represent the respective cytosolic fractions.
(B) Immunofluorescence data. NIH 3T3 cells stably expressing human a5 were transiently transfected with plasmids expressing GFP-
tagged full-length Nischarin. Cells were grown on fibronectin-coated coverslips, fixed, stained with anti-vinculin antibody (Sigma-
Aldrich) and rhodamine-labeled secondary antibody, and observed by two-color fluorescence microscopy. Subcellular distribution of
Nischarin–GFP was visualized by examination of green fluorescence. Cells transfected with Nischarin–GFP are marked by large white
arrows. Representative vinculin-rich focal contacts are marked by small white arrowheads.The Journal of Cell Biology, Volume 151, 2000 1148
by subcellular fractionation. Cos7 cells were transfected
with plasmids expressing myc-tagged full-length Nischarin.
These cells, as well as untransfected Neuro 2A cells, were
fractionated as described in Materials and Methods. Frac-
tions containing membranes or 100,000 g supernatant were
prepared, resolved by SDS-PAGE, and subjected to West-
ern blotting with chicken anti-Nischarin antibodies (Fig. 6
A). Both transfected and endogenously expressed Nis-
charin were primarily found in the 100,000 g supernatant
fraction, indicating that Nischarin is a soluble rather than a
transmembrane protein.
We have used the Nischarin–GFP chimera described in
Materials and Methods and fluorescence microscopy to
obtain further information on the subcellular localization
of Nischarin (Fig. 6 B). NIH 3T3 cells expressing the Nis-
charin–GFP chimera were counterstained with antibodies
to the focal contact protein vinculin (Fig. 6 B). Nischarin–
GFP did not enter the nucleus and was primarily found
diffusely distributed in the cytosol. However, a greater
concentration of Nischarin was seen in the perinuclear re-
gion partially associated with punctate structures that may
be endomembrane vesicles. There was no evidence of Nis-
charin–GFP accumulation at vinculin-rich focal adhesion
sites. Staining of focal contacts and fibrillar structures with
anti-a5 antibody also failed to reveal any obvious colocal-
ization with Nischarin (not shown). Similar studies using
an antiphosphotyrosine antibody to detect focal contact
sites yielded the same result (data not shown). Thus, Nis-
charin is found primarily in the cytosol, with some concen-
tration in the perinuclear area, but does not concentrate at
“classical” focal adhesion sites.
The observations in Fig. 6 indicate that Nischarin is
largely a cytosolic protein, and its overall distribution does
not coincide with focal adhesion structures. Since Nis-
charin can clearly associate with the a5 subunit, as demon-
strated by coimmunoprecipitation, this may indicate that
only a small fraction of the total cellular pool of Nischarin
is associated with the a5b1 integrin at any given time.
Nischarin Inhibits Cell Migration
To investigate the biological role(s) of Nischarin, we fo-
cused on the finding that Nischarin seems to interact most
strongly with the a5 subunit and on the knowledge that
a5b1 plays an important role in cell motility. The effect of
Nicharin on cell migration was initially evaluated using a
monolayer “wounding” assay (Bauer et al., 1993). NIH
3T3 cells were cotransfected with various amounts of
a plasmid expressing full-length Nischarin and with a
b-galactosidase marker plasmid. After transfection and
recovery, the transfected cell monolayers were scraped with
a razor blade. The migration of transfected (b-galactosidase
positive) cells across the wound boundary was quantitated,
as described in Materials and Methods. As seen in Fig. 7 A,
cells overexpressing Nischarin showed significant inhibition
of migration compared with cells transfected with b-galac-
tosidase plasmid alone. Increasing the dose of Nischarin
plasmid resulted in a progressive decrease in migration.
This is unlikely to be due to toxicity since increasing the
amount of Nischarin transfected did not reduce the survival
of the transfectants, as judged by the fraction of b-galactosi-
dase–positive cells in the total cell population.
Nischarin effects on cell movement were also evaluated
using a transwell assay (Keely et al., 1997) where the cells
migrate across a membrane containing 8 mm pores. These
studies also undertook to examine whether the effect of
Nischarin on migration displayed any specificity in terms
of the integrin involved in migration. One set of experi-
ments used CHO sublines differing in a5b1 expression
(Bauer et al., 1993). CHO B2 cells lack a5b1 and do not
Figure 7. Effects of Nischarin overexpression on cell migration.
Mouse 3T3 fibroblasts or CHO cells were transfected with vari-
ous amounts of a plasmid expressing myc-tagged full-length Nis-
charin, and cotransfected with a marker plasmid (A, b-galactosi-
dase for wound-type migration assays; B and C, GFP for
transwell assays). The transfected cell populations were then ana-
lyzed for cell migration, either by wound-type assays or transwell
assays, as described in Materials and Methods. (A) An illustra-
tion of the wound-type migration behavior of Nischarin transfec-
tants versus 3T3 cells transfected with b-galactosidase alone. The
amount of transfected Nischarin plasmid is shown on the abcissa;
migration results are reported as percent of the b-galactosidase
only control. (B) An illustration of the transwell migration be-
havior of a5-deficient CHO B2 cells or a5-expressing CHO
B2a27 cells on membranes coated with 10 mg/ml fibronectin (Fn)
or vitronectin (Vn). Light bars represent cells transfected only
with GFP plasmid, whereas dark bars represent cells transfected
with GFP and 2 mg of Nischarin plasmid. Results are presented as
percent of the GFP control for each cell type and coating. Treat-
ment of B2a27 cells with 2 mg/ml of cytochalasin D is used as a
negative control to illustrate total inhibition of migration. It
should be noted that CHO B2 cells do not adhere to surfaces
coated with fibronectin and thus cannot migrate on these sur-
faces. (C) An illustration of the transwell migration of 3T3 cells
stably transfected with human a5 or a2 and plated on mem-
branes coated with 10 mg/ml fibronectin (Fn) or collagen (Cl), re-
spectively. Light bars represent cells transfected only with GFP
plasmid, whereas dark bars represent cells transfected with GFP
and 2 mg of Nischarin plasmid. Results in A–C represent the
means and standard errors of three determinations.Alahari et al. Novel Integrin-binding Protein Inhibits Cell Migration 1149
Figure 8. Effects of Nischarin on
cytoskeletal organization. REF
cells were transiently transfected
with a plasmid-expressing full-
length Nischarin and cotrans-
fected with a marker plasmid ex-
pressing GFP. After 48 h, the
cells were replated on fibronec-
tin-coated cover slips for 3 h and
processed for immunofluores-
cence, as described in Materials
and Methods. (A) TRITC-phal-
loidin staining of the actin cy-
toskeleton in Nischarin transfec-
tants (NIS) and in control cells
transfected only with the GFP
plasmid (GFP). The transfected
cells expressing GFP are marked
with arrows. (B) Cells stained
for the focal contact markers
vinculin (VIN) or phosphoty-
rosine (PY) using a TRITC-
labeled secondary antibody and
visualized using a filter for red
fluorophores. Transfected cells
expressing GFP are visualized
using a filter for green fluoro-
phores; the GFP-expressing cells
are marked with arrows.The Journal of Cell Biology, Volume 151, 2000 1150
adhere to fibronectin, but express other integrins that al-
low adhesion and migration on vitronectin or other matrix
proteins. CHO B2a27 cells derive from B2, but have been
stably transfected with human a5; these cells migrate on fi-
bronectin in a completely a5b1-dependent manner. The
transwell membranes for these assays were coated with ei-
ther fibronectin or vitronectin. As seen in Fig. 7 B, trans-
fection of B2a27 cells with Nischarin led to a major reduc-
tion of their migration on fibronectin-coated membranes,
but only a modest reduction on vitronectin-coated mem-
branes. Furthermore, migration of the B2 cells on vitro-
nectin-coated membranes was not at all affected by ex-
pression of Nischarin. Treatment of cells with cytochalasin
D completely abolished migration of either cell type.
In another set of experiments, transwell migration as-
says were performed with 3T3 cells stably transfected with
human a5 or a2 subunits (Aplin et al., 1999b). The adhe-
sion, and presumably migration, of these cells is strongly
influenced by the transfected integrin subunit. As seen in
Fig. 7 C, transfection with Nischarin markedly inhibited
migration of the a5-overexpressing cells on fibronectin,
but had little effect on the migration of the a2-overex-
pressing cells on collagen.
Thus, Nischarin overexpression can profoundly inhibit
cell migration. This effect displays substantial integrin sub-
unit specificity and is much more dramatic for migration
on fibronectin mediated by a5b1 than for migration on
other matrix proteins mediated by other integrins.
Effects of Nischarin on the Cytoskeleton
Since overexpression of Nischarin resulted in substantial
alterations in cell migration, we wished to determine if this
was accompanied by changes in the organization of the cy-
toskeleton. REF cells were transfected with plasmids ex-
pressing full-length Nischarin and GFP. Cells were probed
with the actin-binding reagent phalloidin or were immu-
nostained for phosphotyrosine, vinculin, tubulin, or vimen-
tin. Phalloidin staining (Fig. 8 A) indicated that many of
the transfected REF cells had a unique phenotype, with a
more or less circular shape and having actin filaments ar-
ranged in “basket” structures around the periphery, rather
than as the linear stress fibers commonly seen in adherent
fibroblasts. Although this phenotype was not universal,
z60% of the REF cells cotransfected with Nischarin and
GFP showed the basket-like actin structures. In contrast,
only a few percent of the control GFP transfectants had
this phenotype. We next looked for the effects of Nis-
charin on focal adhesions by staining for vinculin and
phosphotyrosine. As seen in Fig. 8 B, vinculin-containing
focal contacts and phosphotyrosine in focal contacts were
somewhat reduced in REF cells transfected with Nischarin
compared with control cells. Staining, with anti-tubulin or
anti-vimentin antibodies, suggested that Nischarin expres-
sion had little effect on the organization of microtubules
or intermediate filaments in REF cells (not shown). Simi-
lar effects were observed in WI-38 cells, another well
spread cell line (not shown). However, the “basket” phe-
notype was not apparent in Nischarin-transfected NIH
3T3 cells or in Cos7 cells, both of which are less well
spread. The highly organized actin filaments of REFs may
allow easier visualization of the relatively subtle effects of
Nischarin on cytoskeletal architecture.
Figure 9. Effects of Nischarin on signaling by Rac GTPase.
Mouse 3T3 cells were transiently cotransfected with a plasmid
containing luciferase driven by the c-fos promoter, with plas-
mids expressing activated forms of the Rac GTPase, or with a
plasmid expressing activated MEK, and with various amounts
of a plasmid expressing full-length myc-tagged Nischarin. All
transfections were normalized for total DNA using vector plas-
mid. Nischarin expression was confirmed by Western blotting
(not shown). Activation of the luciferase reporter was deter-
mined by luminometry and normalized based on total cell pro-
tein. (A) An anti-AU epitope Western blot for expression of
transfected AU-epitope–labeled Rac, with or without cotrans-
fection with 2 mg Nischarin plasmid. The control is the blot for
untransfected 3T3 cells. (B) An illustration of the effect of
transfection with the plasmid pAX142 RacQ61L(Rac) in acti-
vating the c-fos–luciferase reporter (Luc) and the effects of
cotransfection with various amounts (shown in mg) of Nischarin
plasmid. Transfection with the pAX142 “empty” vector (Pax)
serves as a negative control. (C) An illustration of the effects of
transfection with the plasmid pAX142 RacQ61L(Rac) (dark
bars) or the plasmid pFC-MEK1 (light bars) in activating the
c-fos luciferase reporter (both normalized to 100%) and the ef-
fects of cotransfection with 0.1–0.5 mg of Nischarin plasmid
(Nis). Results in A–C are the means and standard errors of
three determinations.Alahari et al. Novel Integrin-binding Protein Inhibits Cell Migration 1151
Effects of Nischarin on Rac GTPase-mediated Signaling
Since the organization of the actin cytoskeleton, as well as
cell motility, are strongly influenced by the activity of the
Rac GTPase (Mackay and Hall, 1998), we decided to eval-
uate whether Nischarin might affect Rac-mediated func-
tions. As an initial test of the effects of Nischarin on signal-
ing by Rac, NIH 3T3 cells were transfected with a reporter
plasmid that uses the c-fos promoter to drive luciferase ex-
pression. Cells were then cotransfected with plasmids ex-
pressing activated versions of Rac, as well as with various
amounts of a plasmid expressing full-length Nischarin. As
seen in Fig. 9 A, transfection with Nischarin plasmid did
not affect levels of expression of cotransfected Rac. Acti-
vated Rac strongly stimulated luciferase expression (Fig. 9
B), most likely through well-known effects on transcription
factors that recognize the serum response element (SRE)
in the c-fos promoter (Hill et al., 1995). However, coex-
pression of Nischarin blocked Rac-mediated stimulation of
the c-fos–Luc reporter in a dose-dependent manner (simi-
lar effects were observed with activated CDC42, whereas
much more modest effects of Nischarin were observed
with Rho, not shown). This inhibition was not due to non-
specific effects on transcription or translation, since stimu-
lation of c-fos–Luc by a plasmid expressing constitutively
active MEK was only weakly affected by coexpression of
Nischarin (Fig. 9 C). Thus, Nischarin strongly inhibits sig-
naling mediated by Rac, but is less effective in blocking sig-
naling mediated by an effector in the Erk/MAPK cascade.
The amount of Nischarin plasmid required to strongly
block Rac-induced activation of the c-fos reporter corre-
lates well with the amount that produces a dramatic reduc-
tion in cell migration (compare Figs. 7 and 9). A similar
strong inhibition of reporter gene expression by Nischarin
was also observed using a commercial system that detects
Rac-driven activation of c-Jun. Furthermore, Nischarin
only modestly inhibited expression of a reporter gene that
is responsive to protein kinase A–mediated activation of a
CRE element (Reddig, P., and R.L. Juliano, unpublished
observations). Thus, overexpression of Nischarin seems to
preferentially affect signaling through Rac-driven path-
ways rather than other well-known signaling pathways.
To further evaluate the possible interplay between Nis-
charin and the Rac GTPase, we examined the effect on
Nischarin on a characteristic cytoskeletal function of Rac,
namely the enhanced formation of lamellipodia (Mackay
and Hall, 1998). NIH 3T3 cells were transfected with a
plasmid expressing an activated form of Rac (Q61L), and,
in some cases, were cotransfected with full-length Nis-
charin. A small amount of a GFP plasmid was used to
mark the transfected cells. As seen in Fig. 10 A, expression
of activated Rac produced the expected enhancement of
lamellipodia formation, with .80% of the transfectants
showing large and distinct areas of membrane ruffling.
When cells were cotransfected with active Rac and Nis-
charin there was a strong inhibition of the Rac effect, with
only z35–40% of the cells displaying large lamellipodia
when higher doses of Nischarin were transfected (Fig. 10
C). Some of the Rac plus Nischarin–transfected cells re-
sembled untransfected 3T3 cells (Fig. 10 B). However, var-
ious cells at each dose of Nischarin displayed intermediate
phenotypes with partial ruffling and incomplete lamellipo-
dia (not shown). Thus, overexpression of Nischarin can in-
hibit lamellipodia formation, one of the most characteris-
tic effects of Rac on the cytoskeleton and associated with
cell movement. These findings suggest that Nischarin in-
hibits cell migration, at least in part, through its actions on
pathways regulated by the Rac GTPase.
Figure 10. Inhibition of Rac-induced lamellipodia formation by
Nischarin. NIH 3T3 cells were transiently cotransfected with
RacQ61L and vector alone (A), or RacQ61L and Nischarin (B).
To monitor transfected cells, a GFP plasmid was also included.
After 48 h of transfection, cells were serum starved for 4 h,
trypsinized, and plated onto fibronectin-coated coverslips for
4 h. Actin polymerization was visualized by staining with
rhodamine-phalloidin, as described above. Transfected cells
positive for GFP are marked with large white arrows. Areas of
lamellipodia formation are marked with white arrowheads. (C)
The effect of increasing amounts of cotransfected Nischarin
plasmid on the number of Rac-transfected cells displaying large
lamellipodia.The Journal of Cell Biology, Volume 151, 2000 1152
Discussion
Recent studies suggest that individual integrin a/b het-
erodimers can play unique roles in the regulation of cell
migration, growth, survival, and differentiation (Pozzi et
al., 1998; Farrelly et al., 1999; Liu et al., 1999; Lochter et
al., 1999; Sastry et al., 1999; Lee and Juliano, 2000). This
may come about via specific interactions between the cy-
toplasmic domains of individual integrins and intracellular
proteins involved in signal transduction or other aspects of
cell regulation. The a5b1 integrin is particularly interest-
ing in this regard, since it has been implicated in the con-
trol of both cell growth and programmed cell death (Var-
ner et al., 1995; Zhang et al., 1995; O’Brien et al., 1996;
Sastry et al., 1999; Lee and Juliano, 2000). Here, we have
reported the identification and characterization of mouse
Nischarin, a soluble intracellular protein that is capable of
interacting with the cytoplasmic domain of the integrin a5
subunit. Using both two-hybrid analysis and coimmuno-
precipitation of expressed proteins in cells, Nischarin was
found to interact with the a5 subunit much more strongly
than with the other two a subunits tested. Furthermore,
immunoprecipitation of endogenous a5b1 from a mouse
neuronal cell line resulted in coimmunoprecipitation of
endogenous Nischarin. Thus, current evidence suggests
that Nischarin interacts preferentially with the a5 subunit,
and this interaction can occur under physiological condi-
tions. However, we cannot rule out the possibility that Nis-
charin may interact with other examples of the many
known  a subunits.
Nischarin bears limited resemblance to identified pro-
teins with a well-known functions. Only two close homo-
logues of Nischarin have been reported in the DNA data
bases. The human homologue of Nischarin has been de-
scribed as a putative imidazoline receptor (Ivanov et al.,
1998) (sequence data available from GenBank/EMBL/
DDBJ under accession no. AF082516). Imidazolines are
thought to be neurotransmitters and, thus, their receptors
would presumably be transmembrane proteins. However,
our results clearly show that endogenous Nischarin is pri-
marily a soluble protein and most likely rules out a role as
a transmembrane neurotransmitter receptor. A second
close homologue of the NH2-terminal region of Nischarin
has been reported from the C. elegans genome project (ac-
cession no. Z69383) and two similar proteins are found in
Drosophila. However, the function of these proteins is
completely unknown. The human protein contains a seg-
ment that is highly homologous to the integrin-binding re-
gion of mouse Nischarin that we detected by two-hybrid
screening. There are also substantial homologies between
the central proline-rich region of Nischarin and portions of
several neurofilament proteins, but the functional signifi-
cance of this is unclear. Examination of the primary se-
quence of Nischarin, using programs that search for com-
mon protein structural or functional motifs, yielded few
clues as to the biological role of this molecule.
Nischarin is expressed in many cell types and is found
both in the adult mouse and in the developing embryo.
Higher amounts of Nischarin are found in neuronal-
derived cell lines than in epithelial cells or fibroblasts, but
some Nischarin is expressed in all of these cell types. West-
ern blotting of various cell lines for endogenous Nischarin
revealed proteins of two distinct sizes; in some cells, an
z190 kD form is found that comigrates with expressed
Nischarin. However, in neuronal cells, a larger form of the
protein is seen. The basis for this difference is currently
unknown, but may reflect cell-type specific alternative
splicing, use of alternate start codons, or posttranslational
modification.
Immunofluorescence and biochemical fractionation stud-
ies indicate that Nischarin is largely a soluble cytosolic
protein. It is clear from fluorescence microscopy studies
that Nischarin is not concentrated in vinculin-rich focal
contacts. Although, one might expect a protein that inter-
acts with a5b1 integrin to be localized to focal contacts,
this is not always the case. For example, members of the
TM4 family of proteins clearly interact specifically with
certain integrins, but TM4 proteins are not found in “clas-
sic” focal contacts (Porter and Hogg, 1998; Berditchevski
and Odintsova, 1999). This is also true of calveolin, which
has been found to interact with certain integrins (Wary et
al., 1996). At present it is unknown whether there is any
physiological regulation of the association between the
a5b1 integrin and Nischarin that might affect its subcellu-
lar distribution.
It seems clear that Nischarin can selectively bind to the
cytoplasmic domain of the a5 integrin subunit, based both
upon two-hybrid analysis and coimmunoprecipitation of
full-length Nischarin with native a5b1 in mammalian cells.
However, at any given time, only a small fraction of the to-
tal Nischarin in a cell is likely to be bound to the integrin,
since most Nischarin is found in the cytosolic fraction. This
type of situation is often seen in signaling pathways, where
only a minority of a cytosolic effector molecule associates
with its membrane-bound partner molecule. The well-
known association between Ras and Raf-1 is a good exam-
ple, where Raf is primarily found in the cytosol, despite its
clear ability to interact with membrane-bound Ras (Wart-
mann et al., 1997; Campbell et al., 1998).
Overexpression of full-length Nischarin results in major
changes in cell behavior and also affects cytoskeletal orga-
nization. The most dramatic aspect is the profound inhibi-
tion of cell migration caused by Nischarin. At this point, it
is unclear whether the reduced cell migration observed in
the “wounding” and transwell assays used here is due to a
reduction in innate motility or to an impairment of direc-
tional movement (Gu et al., 1999). This will be an impor-
tant issue for further investigation. The effects of Nis-
charin on cell migration are quite a-subunit selective.
Thus, a5b1-dependent migration on fibronectin is inhib-
ited far more strongly than migration on other substrata
mediated by other integrins.
The overexpression of Nischarin in certain fibroblasts
leads to substantial changes in focal contact and actin fila-
ment organization. Thus, Nischarin-transfected REF cells
display fewer linear stress fibers and a reduction in ma-
ture, vinculin-positive focal contacts. Instead, the actin fil-
aments form unusual “basket” structures around the cell
periphery. These effects are clearly seen in well spread fi-
broblasts such as REF and WI-38 cells, but are much less
apparent in cell lines such as 3T3 and Cos. The dramatic
effects of Nischarin on cell migration and actin filament
organization described here may be due, at least in part, to
the fact that the transfected molecule is expressed at sub-Alahari et al. Novel Integrin-binding Protein Inhibits Cell Migration 1153
stantially higher levels than the normal amount of endoge-
nous Nischarin. However, even the somewhat skewed ef-
fects triggered by overexpression may provide important
clues in eventually ascertaining the physiological role of
Nischarin.
The observed effects of Nischarin on cell motility and
cytoskeletal organization suggested that Nischarin might
impact the pathways used by some Rho-family GTPases to
regulate individual pools of actin filaments (Mackay and
Hall, 1998). Thus, it was satisfying to find that overexpres-
sion of Nischarin strongly blocked the ability of active
forms of Rac to drive reporter gene expression from the
serum-response element of the c-fos promoter. Failure to
strongly block MEK-induced activation of this same pro-
moter indicates that Nischarin acts preferentially on Rac-
mediated events rather than other signaling cascades. The
theme that Nischarin can block Rac functions clearly asso-
ciated with cytoskeletal organization and cell motility was
extended by the observation that Nischarin can inhibit or
reverse the well-known action of Rac in promoting lamel-
lipodia formation. Thus, it seems likely that Nischarin can
have a substantial impact on the signaling and cytoskeletal
functions of Rac. There is little in the primary sequence of
Nischarin to suggest a mechanism for its influence on Rac
GTPase pathways, that is, no obvious homologies to ex-
change factor, GAP, or GDI domains (Sasaki and Takai,
1998) are apparent.
Lately, the mechanistic basis underlying integrin-medi-
ated cell movement has received a good deal of attention.
It is clear that FAK is a key regulator of cell migration in
most cells (Ilic et al., 1995; Cary et al., 1998; Sieg et al.,
2000). Overexpression of the PTEN tumor suppressor, a
dual specificity phosphatase, results in the dephosphoryla-
tion of FAK and a reduction in directional cell motility
(Tamura et al., 1998; Gu et al., 1999). The focal contact
protein p130Cas is tyrosine phosphorylated by FAK; sub-
sequently, the adaptor protein Crk can bind phosphoty-
rosyl sites on Cas. The Cas–Crk complex has been impli-
cated in the control of cell migration, whereas the Rac
GTPase seems to be a downstream mediator of the Cas/
Crk pathway (Cary et al., 1998; Klemke et al., 1998). In ep-
ithelial cells, an important connection has been made be-
tween cell motility and a signaling pathway involving
phosphatidyl inositol-3-kinase and the Rac and CDC42
GTPases (Keely et al., 1997; Shaw et al., 1997). Interest-
ingly, integrin-mediated cell adhesion has been shown to
directly activate Rac and CDC42 (Price et al., 1998),
whereas Ras, CDC42, Rac, and Rho have all been impli-
cated in cooperative regulation of cell movement (Clark
and Brugge, 1995; Nobes and Hall, 1999). Thus, though
many of the molecular details remain to be determined, it
seems clear that a pathway (perhaps branched) involving
integrins, FAK, Cas/Crk, phosphatidyl inositol-3-kinase,
and Rho-family GTPases positively regulates cell motility.
However, other than the role of PTEN in FAK dephos-
phorylation, there has been little evidence, to date, of
physiological inhibitors of cell motility. In this context,
Nischarin may play an important role by negatively im-
pacting cell motility pathways controlled by Rac.
In summary, we have identified and characterized a
novel protein that we have named Nischarin. This protein
can bind selectively to the cytoplasmic tail of the integrin
a5 subunit. Overexpression of Nischarin has potent effects
in terms of retarding cell migration, and it acts preferen-
tially on migration mediated by the a5b1 integrin. Nis-
charin overexpression also influences actin filament orga-
nization in some cell types. These effects may be mediated
through Nischarin’s selective action on pathways regu-
lated by the Rac GTPase. Thus, one important aspect of
Nischarin’s biological role may be to counterbalance the
effects of Rac in promoting directed cell movement.
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